Literature DB >> 3581459

Controlled trial of house dust mite avoidance in children with mild to moderate asthma.

D R Gillies, J M Littlewood, J K Sarsfield.   

Abstract

Twenty-six asthmatic children participated in a controlled trial of house dust mite avoidance. Group A (n = 14) had 12 weeks' avoidance, provided that they had not deteriorated at the end of the first 6 weeks. Group B (n = 12) had an initial 6 weeks' observation period followed by 6 weeks' avoidance. Mite numbers were extremely variable and often low. There was a significant fall in mite numbers in the first, but not the second, 6-week period in group A. In group B there was a significant fall in mite numbers in both the first (observation) and second (active avoidance) periods. Active avoidance produced highly significant falls in total serum IgE. There were no significant changes in IgE during the observation period. This impressive immunological effect was not associated with any changes in the radio-allergo-sorbent assay (RAST) to house dust mite, or symptom scores; peak expiratory flow rates or histamine induced bronchial reactivity. More rigorous avoidance procedures in more severely affected asthmatic patients warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581459     DOI: 10.1111/j.1365-2222.1987.tb02327.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  10 in total

Review 1.  Clinical effects of allergen avoidance.

Authors:  A Custovic; A Woodcock
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

2.  Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study.

Authors:  L H M Rijssenbeek-Nouwens; A J Oosting; M S de Bruin-Weller; I Bregman; J G R de Monchy; D S Postma
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 3.  Allergen exposure and control.

Authors:  E R Tovey
Journal:  Exp Appl Acarol       Date:  1992-11       Impact factor: 2.132

Review 4.  Allergen avoidance in the treatment of asthma and atopic disorders.

Authors:  A Custovic; A Simpson; M D Chapman; A Woodcock
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

Review 5.  Epidemiology of bronchial hyperresponsiveness.

Authors:  A J Woolcock; J K Peat
Journal:  Clin Rev Allergy       Date:  1989

Review 6.  Improving the management of atopic disease.

Authors:  S T Holgate; G Lack
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

7.  House dust mite control measures in the management of asthma: meta-analysis.

Authors:  P C Gøtzsche; C Hammarquist; M Burr
Journal:  BMJ       Date:  1998-10-24

Review 8.  A meta-analysis of baseline characteristics in trials on mite allergen avoidance in asthmatics: room for improvement.

Authors:  Frank E van Boven; Nicolette W de Jong; Gert-Jan Braunstahl; Roy Gerth van Wijk; Lidia R Arends
Journal:  Clin Transl Allergy       Date:  2020-01-06       Impact factor: 5.871

Review 9.  House dust mite control measures for asthma.

Authors:  P C Gøtzsche; H K Johansen
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 10.  Environmental risk factors of childhood asthma in urban centers.

Authors:  F J Malveaux; S A Fletcher-Vincent
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.